 To analyse the counselling, prescribing and monitoring practices of Isotretinoin by doctors in my practice.  Are we adhering to guidelines?  Where.

Slides:



Advertisements
Similar presentations
Depression in adults with a chronic physical health problem
Advertisements

Role of the nurse in administration and safe administration PRN medication Legal and ethical aspects of medication administration Role of the multidisciplinary.
Educational Event 23rd & 24th January 2013
Managing the Mental Health Merry Go Round Karalyn Huxhagen B Pharm FPS AACPA.
Presenting Issues Considerations for Counselling and Psychotherapy An Introduction to Counselling and Psychotherapy: From Theory to Practice.
Kinship Care – Client Complexity Preliminary Research Findings ACWA Presenters: Marita Scott & Lynne McCrae.
Phosphate Control - secrets of ‘good’ units Hugh Cairns on behalf of Tyrone Hospital, Royal Berkshire Hospital and King’s.
GP AUDIT PROJECT DR C BHATTACHARJEE (GP) AND DR W BENHAM (GP REGISTRAR) YEAR: SUNNYBANK MEDICAL CENTRE Wyke, Bradford.
Bell Ringer Is there a link between depression and academic performance?
Lecture 3: Health Psychology and Physical Illnesses I (Part 2)
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
Improving adherence. n Provide more information about the drugs and the treatment. n Tailored regimens are easier to comply with, and there has been some.
Clinical Examination and Procedural Skills The assessment of psychomotor skills in WPBA for the MRCGP examination.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2009.
MEDICATION SAFETY: Clozapine Initiation Chart Review
New York State Department of Health AIDS Institute June, 2014
How to use Clinical Evidence to inform clinical decision making A case presentation using the CE review on acne.
Student Fitness to Practise
1 Consent for treatment A summary guide for health practitioners about obtaining consent for treatment Bridie Woolnough Resolution Officer Health Care.
Psychiatric Services in an Emergency Department Prepared by: Kathleen Crapanzano, MD DHH, OMH Medical Director Presented by: Patricia Gonzales, LCSW Acting.
Can a mental health awareness programme increase the confidence of primary care nurses in managing depression? Sally Gardner Nurse Consultant OOH Trainer.
Improving care quality through NMP in the delivery of mental health services Mike Caulfield MSc, PGCE, BSc, DipHE Advanced Nurse Practitioner for Acute.
Improving the Quality of Physical Health Checks
Quality of Life and Depression as Determinants of Treatment Adherence in Hypertensive Leonelo E. Bautista 1 ; Paul Smith 2 ; Cynthia Colombo 2 ; Dennis.
Poster template by ResearchPosters.co.za Independent Pharmacist Prescriber Led Polypharmacy Clinics Pilot in Windsor, Ascot and Maidenhead CCG Melody Chapman,
Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.
15 May 2011 Chris Howse Expensive Pearls: Medicolegal Session Consent.
Exercise and Mental Health Counseling Services Exercise and Mental Health Counseling Services Resources and Expectations for Affiliated Programs.
MEDICINES and Older People Hira Singh Prescribing Adviser (Middlesbrough PCT and Redcar & Cleveland PCT Medicines Management Team) March 2008.
Medicare Annual Wellness Exam Presented by: Susan Duden, CPC. March 24, 2012.
EPILEPSY. Diagnosis Refer to specialist ? < 28 days 50% of referred pts don’t have epilepsy 20% of pts on epilepsy medication have been misdiagnosed Diagnosis.
“Possible Side Effects Include…”: Accutane
Prescribing Errors in General Practice The PRACtICe Study (2012) GMC Investigating Prevalence and Causes.
Primary Care Trigger Tool Manaia Health PHO Linda Holman Quality Leader.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
Access to services for men in Scotland. 2 A brief look at: Some of the statistics and data that are available What do these tell us about how men perceive.
Goodfellow Symposium 25 March 2012 Presentation  Elder abuse  Background  Research Project: –Question –Approach –Results  Questions.
 Only occurs in females  Effects about 1 in every 2,500 births  Caused when a girl is missing a part of the X sex- chromosome.
Reducing psychotropic prescribing in care homes Sue Woodruff Pharmacist – Care Home Co-ordinator, NHS Norfolk.
Joint Dermatologic and Ophthalmic Drugs & Drug Safety and Risk Management Advisory Committee February 26 & 27, 2004 RISK MANAGEMENT OPTIONS FOR PREGNANCY.
New Zealand Pharmacy Services Andi Shirtcliffe B. Pharm, PG Dip (Clin) Pharm, Reg Pharm NZ Chief Advisor – Pharmacy, New Zealand Ministry of Health.
Non fatal deliberate self harm ( DSH) ‘A deliberate non-fatal act, whether physical, drug over dosage or poisoning, done in the knowledge that it was potentially.
Sidney M. Wolfe M.D and Sherri Shubin M.D., M.P.H. Public Citizen’s Health Research Group FDA Drug Safety and Risk Management and Dermatologic and Ophthalmic.
DODAC and DSaRM Advisory Committee August 1, 2007 Pregnancy Registry and Root Cause Analysis Cynthia Kornegay, Ph.D. Division of Drug Risk Evaluation Office.
Protecting children and young people; the responsibilities of all doctors GMC guidance July 2012 Dr Tara Jones, named GP for safeguarding children, NHS.
Special patient groups Module 5. Introduction Worldwide, the majority of people in substitute treatment are men between Even they do not form a.
SUICIDE ATTEMPT DATA IN A SUICIDE PREVENTION PLANNING MODEL Susan E. Becker Ryan Mullins Mesa State College Prevention Planning Model Steps Establish.
Standard 10: Preventing Falls and Harm from Falls Accrediting Agencies Surveyor Workshop, 13 August 2012.
Community Pharmacy Presentation for Hospital Pharmacists July 2015.
Accutane FDA (Section Name - Saver’s Initials) 3/9/00 12:50 PM 1 Risk Management Options Russell Ellison, MD Chief Medical Officer Vice President, Medical.
RESTICTED DRUGS Risk Evaluation and Mitigation Strategies--REMS
Developing a specialist community based service for adolescent drug users Jack Leach Consultant in substance misuse Young persons drug project, Bolton.
1 Joint NDAC/EMDAC Meeting January 13, 2005 Mevacor TM Daily 20 mg Tablets Rx-to-OTC Switch Daiva Shetty, M.D. Division of Over-the-Counter Drug Products.
Audit of psychotropic medication prescribing in EMI nursing homes in Monmouthshire Dr Pauline Ruth Dr Rui Zheng Dr Arpita Chakraborty Dr Usman Mansoor.
NICE Quality Standard 48: Depression in children and young people An audit of adherence to Quality Standards within Camhs Dr. Angela Brennan Principal.
BAD clinical re-audit on isotretinoin Audit contributorsBAD members, with some contributions from non-members LeadsDavid de Berker, Tak Cheung and M Firouz.
An Introduction to Specialist CAMHS in Somerset Mark Conway Schools Link Pilot Manager and Specialist CAMHS Clinician.
Simplifying Cardiovascular Risk Assessment Mixed Methods Audit of MSF’s NCD Mission in Irbid, Jordan – Interim Results Prepared by Dylan Collins 17 June.
3-MINUTE READ WORKING TOGETHER TO SAFEGUARD CHILDREN.
Mike Caulfield MSc, PGCE, BSc, DipHE
Mini-collaborative Medicines management/dementia care
Opioids Aware A resource for patients and HCPs to support prescribing of opioid medicines for pain Sue Mulvenna CDAO NHSE S SW March 2016.
3-MINUTE READ WORKING TOGETHER TO SAFEGUARD CHILDREN.
Within three years will health records be on-line?
WHY GENETIC COUNSELING IS IMPORTANT
Link Between Hearing Loss and Depression This is a very interesting discussion, because everyone want to know “how are hearing loss and depression linked?”
Urgent Care.
1st Line Medication Lorazepam 0.5 mg p.o/i.m
Presentation transcript:

 To analyse the counselling, prescribing and monitoring practices of Isotretinoin by doctors in my practice.  Are we adhering to guidelines?  Where can improvements be made to help mitigate the risks of using Isotretinoin?

 Acne is common and is suffered by most teenagers and up to half of adults  % of young adults have severe acne  Up to half of year olds with acne develop psychological or social problems

 Teratogenecity - Even a single exposure can cause severe birth defects - Review in NZMJ indicated that the pregnancy rate on Isotretinoin in NZ had been underestimated  Increased depression/suicidality - Studies have failed to demonstrate a clear link

 Pre-prescription counselling  Two forms of adequate contraception  Consent form  Baseline LFTs, FBC, fasting lipids, beta HCG (if female), repeated at 1 month and at end of treatment  Monthly pregnancy test and three- monthly LFTs  Regular monitoring of mood

 As of 01 March 2009, General Practitioners and Nurse practitioners became eligible to prescribe fully funded Isotretinoin under SA  Previously access to fully funded medication only through dermatologists  Debate in NZ and internationally, strong opposition by dermatologists

Arguments for: Arguments against:  GPs have better awareness of overall history  GPs are better placed to address counselling issues and contraception  GPs experienced in prescribing complex medicines  Avoid long travel and wait times to see a specialist dermatologist  GPs lack training and my find it difficult to ascertain dose requirement  Larger number of pregnancy exposures  Larger exposure to potential mental health side effects  Dermatologists see more acne patients  Pressure to prescribe

PHARMAC Consultation Letter(30 th October, 2008)

 Medtech32 query build searching for prescriptions of Isotretinoin from 01/03/2009 to present day  Difficulties with change in trade name  Classifications for “Acne Vulgaris” and special authority submissions  16 patients identified  Analysed pre-prescription counselling, consent procedures, contraception advice, mood monitoring, blood monitoring and side effects

 56% female, 44%male  Age range 14 to 51, mean age 17.8 years  Documented discussion of adverse effects in all but 1 patient  Consent in medtech in 56%  Discussion about need for 2 forms of contraception documented in 57% of applicable

 BetaHCG ordered with baseline bloods in 75% of women but measured sporadically after that  Three monthly bloods were ordered in 81% but only 63% were undertaken  Documentation of mood monitoring in 44%, 13% had a known history of depression

 79% with dry skin, lips and eyes  Other side effects – muscle aches, ↑cholesterol, and deranged LFTs (all 7% each)  Two patients stopped treatment due to significant side effects, one for hair loss and the other due to suicidality

 Isotretinoin is being prescribed appropriately  Pre-prescription counselling – mostly done over one session  Lack of documented consent, selection of appropriate consent form  BetaHCGs not routinely checked prior to prescriptions  Patient compliance with blood tests  Serious risk of harm with 2 out of 16 patients with significant side effects

 Two sessions for initial consultation  Best practice consent form  Mandatory beta-HCGs prior to every prescription  Adequate documentation of mood at every consult  Strategies to improve patient compliance  Best Practice Decision Support module is a good tool to use

 Comparing results with GP practices from different areas, particularly looking at whether access to Isotretinoin has truly improved  Comparing results with dermatologists to see if there are any differences in how well we monitor our patients